title: The Application of Genomics in Diabetes: Barriers to Discovery and Implementation.
abstract: The emerging availability of genomic and electronic health data in large populations is a powerful tool for research that has drawn interest in bringing precision medicine to diabetes. In this article, we discuss the potential application of genomics to the prediction, prevention, and treatment of diabetes, and we use examples from other areas of medicine to illustrate some of the challenges involved in conducting genomics research in human populations and implementing findings in practice. At this time, a major barrier to the application of genomics in diabetes care is the lack of actionable genomic findings. Whether genomic information should be used in clinical practice requires a framework for evaluating the validity and clinical utility of this approach, an improved integration of genomic data into electronic health records, and the clinical decision support and educational resources for clinicians to use these data. Efforts to identify optimal approaches in all of these domains are in progress and may help to bring diabetes into the era of genomic medicine.
authors.affiliation: Cardiovascular Health Research Unit and Departments of Epidemiology and Medicine, University of Washington, Seattle, WA jfloyd@uw.edu.
authors.forename: James S
authors.initials: JS
authors.lastname: Floyd
authors.affiliation: Cardiovascular Health Research Unit and Departments of Epidemiology and Medicine, University of Washington, Seattle, WA.|Department of Health Services, University of Washington, Seattle, WA.|Group Health Research Institute, Seattle, WA.
authors.forename: Bruce M
authors.initials: BM
authors.lastname: Psaty
mesh_terms: D003920:Diabetes Mellitus / Q000517:prevention & control / Q000628:therapy*; D057286:Electronic Health Records; D023281:Genomics; D006801:Humans; D057285:Precision Medicine; D012106:Research; D018570:Risk Assessment